Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FMNB
|
Edward Muransky |
BUY
Open market or private purchase
|
Direct | 280 Added 0.71% |
$3,752
$13.4 p/Share
|
Feb 01
2021 |
|
FMNB
|
Terry A Moore |
BUY
Open market or private purchase
|
Direct | 358 Added 0.81% |
$4,797
$13.4 p/Share
|
Feb 01
2021 |
|
FMNB
|
Kevin J Helmick
President & CEO |
BUY
Open market or private purchase
|
Direct | 37 Added 0.04% |
$496
$13.4 p/Share
|
Feb 01
2021 |
|
ITHX
|
Ithax Acquisition Sponsor, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 465,000 Added 50.0% |
-
|
Feb 01
2021 |
|
ITHX
|
Orestes Fintiklis
Director |
BUY
Open market or private purchase
|
Indirect | 465,000 Added 50.0% |
-
|
Feb 01
2021 |
|
ITHX
|
Dimitrios Athanasopoulos
CFO; Treasurer |
BUY
Open market or private purchase
|
Indirect | 465,000 Added 50.0% |
-
|
Feb 01
2021 |
|
WNEB
|
Laura Benoit
Director |
BUY
Open market or private purchase
|
Direct | 250 Added 0.9% |
$1,638
$6.55 p/Share
|
Feb 01
2021 |
|
APEN
|
Neil Gagnon
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 473 Added 0.13% |
$1,987
$4.2 p/Share
|
Feb 01
2021 |
|
MLVF
|
Stephen P Scartozzi
Director |
BUY
Open market or private purchase
|
Direct | 167 Added 2.24% |
$2,649
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
Andrew D. Fish
Director |
BUY
Open market or private purchase
|
Direct | 182 Added 3.93% |
$2,887
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
Cynthia F Leitzell
Director |
BUY
Open market or private purchase
|
Direct | 198 Added 1.13% |
$3,140
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
Howard Kent
Director |
BUY
Open market or private purchase
|
Direct | 255 Added 0.16% |
$4,044
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
Norman Feinstein
Director |
BUY
Open market or private purchase
|
Indirect | 197 Added 1.45% |
$3,124
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
Julia D Corelli
Director |
BUY
Open market or private purchase
|
Direct | 167 Added 2.26% |
$2,649
$15.86 p/Share
|
Feb 01
2021 |
|
MLVF
|
James W Barrett
Director |
BUY
Open market or private purchase
|
Direct | 167 Added 1.27% |
$2,649
$15.86 p/Share
|
Feb 01
2021 |
|
FUNC
|
Gary Ruddell
Director |
BUY
Open market or private purchase
|
Direct | 11 Added 0.05% |
$174
$15.86 p/Share
|
Feb 01
2021 |
|
FUNC
|
Carissa Lynn Rodeheaver
Chairman, President & CEO |
BUY
Open market or private purchase
|
Direct | 82 Added 0.31% |
$1,301
$15.86 p/Share
|
Feb 01
2021 |
|
FUNC
|
John Mc Cullough
Director |
BUY
Open market or private purchase
|
Direct | 398 Added 0.82% |
$6,189
$15.55 p/Share
|
Feb 01
2021 |
|
FUNC
|
Brian R. Boal
Director |
BUY
Open market or private purchase
|
Direct | 14 Added 0.13% |
$222
$15.86 p/Share
|
Feb 01
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 405 Added 0.38% |
$6,043
$14.92 p/Share
|
Feb 01
2021 |
|
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 80,000 Added 1.21% |
$935,200
$11.69 p/Share
|
Feb 01
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
BUY
Open market or private sale
|
Direct | 2,325 Added 77.89% |
$59,218
$25.47 p/Share
|
Feb 01
2021 |
|
NRDY
|
Light Street Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 123,619 Added 2.6% |
$1,328,904
$10.75 p/Share
|
Feb 01
2021 |
|
XPMIX
|
Neil David Menard
President of Distribution / |
BUY
Open market or private purchase
|
Indirect | 5,971 Added 37.45% |
$186,833
$31.29 p/Share
|
Feb 01
2021 |
|
XPMIX
|
Ron D. Sturzenegger
Director |
BUY
Open market or private purchase
|
Direct | 15,979 Added 30.75% |
$499,983
$31.29 p/Share
|
Feb 01
2021 |
|
XPMIX
|
Robert W. Long
Pres. & Prin. Exec. Officer |
BUY
Open market or private purchase
|
Direct | 3,515 Added 16.96% |
$109,984
$31.29 p/Share
|
Feb 01
2021 |
|
XPMIX
|
Thomas Kent Sittema
Director |
BUY
Open market or private purchase
|
Direct | 3,195 Added 16.31% |
$99,972
$31.29 p/Share
|
Feb 01
2021 |
|
ATLO
|
Kevin L Swartz
Director |
BUY
Open market or private purchase
|
Direct | 400 Added 16.13% |
$8,940
$22.35 p/Share
|
Feb 01
2021 |
|
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 1,119 Added 0.07% |
$15,845
$14.16 p/Share
|
Feb 01
2021 |
|
EBMT
|
Corey Jensen
Director |
BUY
Open market or private purchase
|
Direct | 450 Added 13.39% |
$9,967
$22.15 p/Share
|
Feb 01
2021 |
|
DFCO
|
Brian Bonar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 0.03% |
$660
$0.44 p/Share
|
Feb 01
2021 |
|
RCUS
|
Gilead Sciences Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 5,650,000 Added 28.88% |
$220,350,000
$39.0 p/Share
|
Jan 31
2021 |
|
MNKD
|
Steven B. Binder |
BUY
Open market or private purchase
|
Direct | 1,557 Added 0.39% |
$2,071
$1.33 p/Share
|
Jan 31
2021 |
|
MNKD
|
Stuart A Tross
Chief People & Workpl Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.03% |
$6,650
$1.33 p/Share
|
Jan 31
2021 |
|
MNKD
|
Michael Castagna
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.45% |
$6,650
$1.33 p/Share
|
Jan 31
2021 |
|
ED
|
Robert Sanchez
President, Shared Services |
BUY
Open market or private purchase
|
Direct | 32 Added 0.8% |
$2,265
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Stuart Nachmias
President & CEO CET |
BUY
Open market or private purchase
|
Direct | 9 Added 0.83% |
$637
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Gurudatta D Nadkarni
VP, Strategic Planning |
BUY
Open market or private purchase
|
Direct | 29 Added 0.36% |
$2,053
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Joseph Miller
VP & Controller |
BUY
Open market or private purchase
|
Direct | 3 Added 0.33% |
$212
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Matthew Ketschke
President, CECONY |
BUY
Open market or private purchase
|
Direct | 1 Added 0.17% |
$71
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Robert N Hoglund
SVP & CFO |
BUY
Open market or private purchase
|
Direct | 32 Added 0.08% |
$2,265
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Deneen L Donnley
SVP and General Counsel |
BUY
Open market or private purchase
|
Direct | 32 Added 4.64% |
$2,265
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Timothy Cawley
Chairman, President & CEO |
BUY
Open market or private purchase
|
Direct | 32 Added 0.2% |
$2,265
$70.78 p/Share
|
Jan 31
2021 |
|
ED
|
Bastide Lore De La
SVP, Utility Shared Services |
BUY
Open market or private purchase
|
Direct | 4 Added 0.55% |
$283
$70.78 p/Share
|
Jan 31
2021 |
|
EXPI
|
Stacey Onnen
President, U.S. Brokerage Ops |
BUY
Open market or private purchase
|
Direct | 1 Added 3.13% |
$48
$47.96 p/Share
|
Jan 31
2021 |
|
VISM
|
Mark Burdon Lucky
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500,000 Added 0.16% |
$5,000
$0.01 p/Share
|
Jan 29
2021 |
|
AIRT
|
Raymond E Cabillot
Director |
BUY
Open market or private purchase
|
Indirect | 1,291 Added 0.33% |
$26,143
$20.25 p/Share
|
Jan 29
2021 |
|
AIRT
|
Nicholas John Swenson
CEO |
BUY
Open market or private purchase
|
Indirect | 1,292 Added 0.14% |
$26,163
$20.25 p/Share
|
Jan 29
2021 |
|
MBCN
|
Michael C Voinovich
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 19.86% |
$19,600
$19.6 p/Share
|
Jan 29
2021 |
|
TDY
|
Robert Mehrabian
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 1.9% |
$3,674,700
$367.47 p/Share
|
Jan 29
2021 |